ArticleHaematologica2019

Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib.

Dylan Graetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.